Health Care Cutting biosimilar red tape could save billions Europe designates all biosimilars as interchangeable with original biologics. It's time for the United States to do the same.
Prescription Drugs New FDA chief pressured to slow the pace of new drug approvals In order to accelerate FDA approval of more drugs, the agency should be more willing to pull drugs that fail in the real world.